Remus Pharmaceuticals Share price

The Company was originally incorporated as ‘Remus Pharmaceuticals Private Limited’ as a private limited company under the provisions of the Companies Act 2013 vide Certificate of Incorporation dated September 21 2015 issued by the Assistant Registrar of Companies Gujarat. Later on pursuant to a special resolution passed by the shareholders in the Extra-Ordinary General Meeting held on January 02 2023 the Company was converted from a private limited company to public limited company and consequently the name of the Company was changed to “Remus Pharmaceuticals Limited” and a fresh certificate of incorporation dated January 06 2023 was issued to the Company by the Registrar of Companies Ahmedabad. The Corporate Identification Number of the Company is U24232GJ2015PLC084536.The Promoters Mr. Arpit Deepakkumar Shah Ms. Roma Vinodbhai Shah and Mr. Swapnil Jatinbhai Shah are associated with the company since incorporation. Mrs. Anar Swapnil Shah joined the company since March 2020. In this dynamic and extremely competitive business environment we have developed a diversified business model. the promoters have a combined experience of more than 36 years in the pharmaceutical industry. Driven by the passion for building an integrated pharmaceutical company backed by their experience the Promoters have been the pillars of the Company's growth and have built a strong value system for the Company. With their enriching experience and progressive thinking we aim to continue to grow in the pharmaceutical industry.The company is engaged in marketing & distribution of finished formulations of pharmaceutical drugs. the company also deals in API (Active Pharmaceutical Ingredient). We also provide technical consultancy services to various distributors for preparation of reports on the dossiers of the products to be registered by them in various countries. Having cultivated strong and dependable customer relationships ranging from Generic distributors regional distributors and Multinational distributors to Hospitals and Clinics through a responsive distribution network the clients are spread in more than 20 countries. We look forward to form long lasting relationships that enhance the lives of the patients.The Company is majorly engrossed in the pharmaceutical business involving marketing trading and distribution of wide range of pharmaceutical finished formulations and products. Depending upon business requirments we get finished pharmacuetical formulations manufactured on loan license or contract manufacturing. Such manufacturing is on principle to principle basis. We have the presence through registered and/or under registration products in countries namely Bhutan Bolivia Chile Costa Rica Cuba Dominican Republic Ecuador El Salvador Guatemala Honduras Jamaica Kuwait Madagascar Malaysia Hong kong Myanmar Panama Trinidad and Tobago Uzbekistan Venezuela Vietnam. We deal in drug forms like Capsules Cream Eye Drops Gel Infusion Inhalation Inhaler Injection Nail Lacquer Nasal Solution Nasal Spray Nebuliser Ointment Ophthalmic Oral Gel Oral Solution Oral Suspension Sachet Suspension Tablet.The product portfolio consists of 429 products as on January 31 2023. We operate under different brand names across the globe. As on January 31 2023 we have 295 products registered in total 13 countries. As on January 31 2023 total 134 products are under process of registration in 16 countries which shall boost the growth of the company. The product portfolio comprises of vide range of therapeutic drugs namely ACE inhibitors Analgesic anaesthetic Antiulcer Anti angiogenic Anti Erectile Dysfunction Anti fibrinolytic Anti histamine Anti-inflammatory Anti-ulcer Anti-acne Antianxiety Antiarrhythmic antiarrhythmic agent Antibiotic Antibiotic Anticancer Anticholinergics Anticoagulant Anticonvulsant Antidepressant Antidiabetic Antidiuretics Antiemetics Antifungal Anti-gastric Antihistaminic Antihypertensive Antimalarial Antioxidants Antiparasitic Antiprotozoal Antipsychotic Antipyretic Antiretroviral Antiretrovirals Anti-seizure Antispasmodic Anti-vertigo Antiviral Asthma Avitaminosis Beta blocker Carcinoid tumours Chronic Obstructive Pulmonary Disease CNS stimulants Contrast Reagent Corticosteroids Corticosteroids Dermatology Hyperprolactinemia Immuno-suppressive Iron chelator (binder) Iron deficiency Menopausal hormone therapy Mucolytic Nasal decongestants non-depolarizing neuromuscular blocker NSAIDs Ocular-hypertension Opioid Antagonists Phosphate binders Potassium deficiency Probiotic selective relaxant binding agent Urology Vaso constrictor and Vitamin deficiency.MAJOR EVENTS :2015- The Company was incorporated as a private limited company under the name “Remus PharmaceuticalsPrivate Limited”.2023- Conversion of the company from Private Limited to Public Limited Company